Table 7. Multifactorial analysis of demographic and clinical characteristics in relation to paxillin positivity and IRS score.
Reference category | Paxillin positivity | Paxillin IRS score | |||||||
OR | 95%CI | p-value | OR | 95%CI | p-value | ||||
Age | 0.97 | 0.933 | 1.02 | 0.239 | 0.97 | 0.92 | 1.02 | 0.174 | |
Gender (female) | Male | 4.20 | 0.990 | 17.90 | 0.052 | 5.70 | 1.26 | 25.80 | 0.024 |
Grade | 0.040 | 0.037 | |||||||
2 | 1 | 2.06 | 0.25 | 17.16 | 0.504 | 1.99 | 0.23 | 17.33 | 0.533 |
3 and 4 | 0.18 | 0.04 | 0.78 | 0.022 | 0.17 | 0.04 | 0.75 | 0.020 | |
Stage Τ | 0.576 | 0.869 | |||||||
2 | 1 | 0.999 | 0.00 | 0.00 | 0.998 | ||||
3 | 2.15 | 0.52 | 8.98 | 0.294 | 1.49 | 0.34 | 6.43 | 0.596 | |
Histologic type | 0.241 | 0.195 | |||||||
Papillary | Clear cell | 4.96 | 0.86 | 28.69 | 0.074 | 5.35 | 0.92 | 31.12 | 0.062 |
Chromophobe | 2.33 | 0.34 | 16.00 | 0.389 | 1.03 | 0.13 | 8.41 | 0.980 | |
Unclassified | 4.98 | 0.57 | 43.33 | 0.146 | 5.72 | 0.65 | 49.93 | 0.115 |